Rise Advisors, LLC 10x Genomics, Inc. Transaction History
Rise Advisors, LLC
- $242 Million
- Q2 2025
A detailed history of Rise Advisors, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Rise Advisors, LLC holds 114 shares of TXG stock, worth $1,443. This represents 0.0% of its overall portfolio holdings.
Number of Shares
114Holding current value
$1,443% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding TXG
# of Institutions
316Shares Held
113MCall Options Held
228KPut Options Held
157K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13.9MShares$176 Million1.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$141 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL7.1MShares$89.9 Million0.02% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$80.9 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.02MShares$76.2 Million0.04% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.2B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...